Clinical Trial Update: A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

View source ↗

Summary

This completed non-interventional study evaluated outcomes in asthma patients treated with Symbicort Turbuhaler over three months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED